Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Emerging Market for Clinical Trials in Argentina by rgunnam

VIEWS: 9 PAGES: 2

Rising Financial and Regulatory Pressures on Western Pharma Will Continue to Drive the Clinical Trial Market Growth in Argentina

More Info
									Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting
Clinical Trials Will Encourage Drug Development

Rising Financial and Regulatory Pressures on Western Pharma Will Continue to Drive the Clinical Trial
Market Growth in Argentina

The pharmaceutical industries of the US and Europe have been facing severe financial constraints
over the past few years, and these are expected to worsen in the coming years. With constraints
such as the cost of introducing an NME increasing to reach more than $3 billion in 2008, tightening
regulatory pressures resulting in fewer FDA approvals, blockbuster drugs worth more than $100
billion set to expire by 2014 and the drying pipelines of the pharmaceutical industry, pressures are
mounting on pharmaceutical companies to cut costs, especially the big ones. These pressures are
expected to drive these companies towards low-cost countries such as Argentina to perform their
R&D activities, one of their major expenses.

Argentina has developed significant capabilities in clinical trials over the last decade, along with
certain capabilities especially for diabetes indication. Argentina is able to provide significant cost
savings in the range of 50–60% for clinical trials. With discovery research occupying close to onethird
of the R&D expenditure for the western pharmaceutical industry, outsourcing to low-cost
countries is logical.

For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Emerging-Market-for-Clinical-Trials-in-
Argentina-Major-Cost-Advantages-over-the-US-in-Conducting-Clinical-Trials-Will-Encourage-Drug-
Development&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report

The figure above depicts the population of Argentina according to age groups from 1980 to 2050.
As evident from the figure, Argentina’s population will experience a dramatic shift in its age
structure. In 2030 its total population is expected to be above 50 million, with 14.5 million of its
people above the age of 50. In 2050, it is estimated that this number will rise to nearly 19.5 million.
This means that there will be a rise in chronic diseases, which generally affect this population age
group.

GBI Research, the leading business intelligence provider, has released its latest report, “Emerging
Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting
Clinical Trials Will Encourage Drug Development”, which provides key data, information and
analysis of the major trends and issues affecting the clinical trial market in Argentina. The report
provides a comprehensive insight into the reasons for outsourcing clinical trials to Argentina and
the key services provided by the CROs of Argentina. The report provides a detailed analysis of the
Argentine market in terms of its size and the major service offerings of the CROs in Argentina. The
report also discusses the factors that are driving the clinical trial market in Argentina. The report
delves into the key documents required by the investigator and the sponsor before, during and after
the conduct of clinical trials. The report also provides key alliances between the CROs of other
countries and the local CROs of Argentina. The report also looks into the major challenges that
could restrict the growth of the clinical trials market in Argentina.

This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GBI Research’s team of industry experts.

For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Emerging-Market-for-Clinical-Trials-in-Argentina-Major-
Cost-Advantages-over-the-US-in-Conducting-Clinical-Trials-Will-Encourage-Drug-
Development&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report

Visit our report store: http://www.gbiresearch.com

For more details contact:

pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe:                +44 207 753 4299
                       +44 1204 543 533
Asia Pacific:          +91 40 6616 6782

								
To top